Nuvo Group
Founded Year
2014Stage
Reverse Merger | IPOTotal Raised
$68MMarket Cap
0.10BAbout Nuvo Group
Nuvo Group develops medical devices. It provides expectant mothers with pregnancy care, a prescription-initiated remote pregnancy monitoring and management system, conducts virtual well-being checks and remote non-stress-tests, and more. The company was founded in 2014 and is based in Tel Aviv, Israel.
Loading...
Nuvo Group's Product Videos
ESPs containing Nuvo Group
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The maternal & fetal health screening market helps to improve patient outcomes by offering remote patient monitoring services & medical devices to diagnose and monitor maternal and fetal health conditions, including maternal preeclampsia, premature birth risk, and fetal oxygenation levels during labor. Some companies supplement their screening products with support services for comprehensive care.…
Nuvo Group named as Leader among 15 other companies, including Babyscripts, Bloomlife, and Sera.
Nuvo Group's Products & Differentiators
Remote non-stress tests
Under provider prescription, remote NSTs with INVU allow for the completion of non-stress-tests, a common and frequent test administered in the last trimester of high risk pregnancies to monitor fetal heart rate and uterine activity, ensuring that a pregnancy is progressing healthily or to quickly identify when intervention is needed. INVU can be used to monitor NSTs wherever mom is scheduled for an assessment under the supervision of her provider. Mom can sit for the NST from the comfort of her own home and see a high-level view of the data while her provider gets an immediate reading of the detailed data from a session, identical to the strip of data they are used to seeing from in-clinic NSTs.
Loading...
Research containing Nuvo Group
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Nuvo Group in 3 CB Insights research briefs, most recently on Jul 18, 2024.
Jul 18, 2024 report
State of Digital Health Q2’24 Report
Nov 11, 2022 report
How tech is making women’s healthcare more equitable and accessibleExpert Collections containing Nuvo Group
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Nuvo Group is included in 7 Expert Collections, including Baby and Kids Tech.
Baby and Kids Tech
1,281 items
Companies developing tech-enabled products and services that primarily serve babies, children up to approximately 12 years old, and their parents.
Beauty & Personal Care
858 items
These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.
Conference Exhibitors
5,302 items
Digital Health 50
300 items
The winners of the second annual CB Insights Digital Health 150.
Digital Health
11,306 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,114 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Nuvo Group Patents
Nuvo Group has filed 44 patents.
The 3 most popular patent topics include:
- midwifery
- obstetrics
- cardiac arrhythmia
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/30/2023 | 4/30/2024 | Tests during pregnancy, Health informatics, Midwifery, Obstetrics, Cardiac arrhythmia | Grant |
Application Date | 1/30/2023 |
|---|---|
Grant Date | 4/30/2024 |
Title | |
Related Topics | Tests during pregnancy, Health informatics, Midwifery, Obstetrics, Cardiac arrhythmia |
Status | Grant |
Latest Nuvo Group News
Feb 24, 2025
Image: Nuvo Group Israel’s Sheba Medical Center ‘s innovation arm ARC has announced a new collaboration with Nuvo Group to develop advanced AI-driven solutions for remote pregnancy monitoring. The partnership aims to enhance maternal and fetal outcomes through technology that supports clinical decision-making and early detection of pregnancy complications. The collaboration will focus on creating AI-based modules that provide clinicians with advanced decision-support tools while enhancing diagnostic capabilities and enabling early intervention. The partners will also conduct population health analysis to improve the quality of prenatal care at the community level. Nuvo’s remote monitoring solution allows expectant mothers to track their pregnancies from home, the workplace, or other locations, improving both the prenatal care experience and pregnancy outcomes. The collaboration will be directed by Dr. Avi Tsur, an OB/GYN and high-risk pregnancy expert who serves as Director of the Women’s Health Innovation Center at Sheba Beyond, the medical center’s virtual hospital. This agreement is part of Sheba’s broader initiative to become one of the world’s first fully-integrated AI hospitals. Through ARC, Sheba is working to transform healthcare using AI to enhance patient care, diagnostics, and personalized treatment approaches. The medical center has established itself as a leader in AI health tech, collaborating with institutions like the Mayo Clinic to integrate advanced AI solutions across its departments. Prof. Eyal Zimlichman, Chief Transformation and Innovation Officer and Director of ARC at Sheba Medical Center, said: “Our partnership with Nuvo represents the future of pregnancy care. Integrating AI-powered solutions into routine prenatal monitoring not only enhances pregnancy outcomes but also demonstrates how technology can revolutionize healthcare worldwide.” Laurence Klein, CEO of Nuvo Intl Group, said: “We are excited to embark on this collaborative commercial and research partnership with Sheba’s ARC, predicated on innovative, AI-driven modules powered by the INVU platform. ARC and Sheba Beyond’s global leadership in advancing remote and hybrid pregnancy care is invaluable, and we look forward to driving meaningful transformation together.” Nuvo’s INVU platform is an FDA-cleared remote pregnancy monitoring and management system that enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring. The system pioneers new data-driven personalized pathways that Nuvo believes can improve future health outcomes. The platform is currently being used by leading health providers and research institutions across the US and Israel, with plans to expand its footprint in both countries. You May Also Like
Nuvo Group Frequently Asked Questions (FAQ)
When was Nuvo Group founded?
Nuvo Group was founded in 2014.
Where is Nuvo Group's headquarters?
Nuvo Group's headquarters is located at Yigal Alon 94. Street, Tel Aviv.
What is Nuvo Group's latest funding round?
Nuvo Group's latest funding round is Reverse Merger.
How much did Nuvo Group raise?
Nuvo Group raised a total of $68M.
Who are the investors of Nuvo Group?
Investors of Nuvo Group include LAMF Global Ventures Corp. I, MedTech Innovator and Shareholder Value Management.
Who are Nuvo Group's competitors?
Competitors of Nuvo Group include Baymatob and 7 more.
What products does Nuvo Group offer?
Nuvo Group's products include Remote non-stress tests and 1 more.
Who are Nuvo Group's customers?
Customers of Nuvo Group include Axia, CANLab, UAMS and UHP.
Loading...
Compare Nuvo Group to Competitors
Bloomlife operates as a women's health company that focuses on improving maternal health through technology in the healthcare sector. The company offers remote patient monitoring and connected devices that provide data analytics for maternal and fetal health, as well as digital health assessments to manage pregnancies. Bloomlife primarily serves healthcare providers and pregnant women. Bloomlife was formerly known as Bloom Technologies. It was founded in 2014 and is based in San Francisco, California.
Marani Health operates as an artificial intelligence (AI)-powered maternal healthcare technology company focused on improving patient outcomes and enhancing clinical workflows in the healthcare sector. The company offers a platform that delivers individual insights through connected devices, enabling personalized and proactive care for pregnant individuals. Marani Health primarily serves maternity providers, health plans, employers, and patients with its solutions for prenatal and postpartum care. Marani Health was formerly known as Odonata Health. It was founded in 2018 and is based in Oakdale, Minnesota.
Nanit specializes in smart baby monitoring technology within the consumer electronics sector. The company offers products that enable parents to track their baby's sleep, breathing, and overall wellness through a connected camera and app, providing insights and analytics to support child development. Nanit's solutions cater to the needs of modern parents seeking data-driven tools for infant care and development. It was founded in 2014 and is based in New York, New York.
Pera Labs specializes in AI fertility solutions and reproductive health services within the health tech industry. The company offers a range of services including fertility and genomic testing, dietary supplements for fertility, and reproductive health counselling. Pera Labs primarily serves individuals and couples seeking fertility treatments and reproductive wellness. It was founded in 2018 and is based in Philadelphia, Pennsylvania.
Coroflo develops a breastfeeding monitor that is integrated into a nipple shield, measuring and displaying how much breastmilk a baby receives during feeding sessions. The product connects to a mobile application to provide data on milk flow and transfer. It was founded in 2016 and is based in Dublin 11, Ireland.
Raydiant Oximetry focuses on improving maternal-fetal medicine by developing noninvasive sensor technology for childbirth. Its main product, Lumerah™, is a fetal pulse oximeter designed to measure fetal oxygen levels accurately and reduce unnecessary cesarean deliveries. The company primarily serves the healthcare sector, offering tools for obstetric providers to evaluate fetal well-being during labor. It was founded in 2016 and is based in San Ramon, California.
Loading...